Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$36,996,096
in 12 filings, $37.0M under 10b5-1 plans

Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-10 Telman Deborah H EVP, Corporate Affairs & GC Grant or award · Restricted Stock Unit +7,680 32,216
2025-03-10 Dickinson Andrew D Chief Financial Officer Option exercise 10b5-1 +4,916 $63.91 $314K 173,977
2025-03-10 Dickinson Andrew D Chief Financial Officer Option exercise 10b5-1 +13,013 $63.91 $832K 186,990
2025-03-10 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −4,916 $117.30 $577K 182,074
2025-03-10 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −13,013 $118.50 $1.5M 169,061
2025-03-10 Dickinson Andrew D Chief Financial Officer Option exercise 10b5-1 +7,968 177,029
2025-03-10 Dickinson Andrew D Chief Financial Officer Shares withheld for taxes 10b5-1 −3,855 $117.21 $452K 173,174
2025-03-10 Dickinson Andrew D Chief Financial Officer Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −4,916 13,013
2025-03-10 Dickinson Andrew D Chief Financial Officer Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −13,013 0
2025-03-10 Dickinson Andrew D Chief Financial Officer Option exercise · Restricted Stock Unit 10b5-1 −7,968 27,519
2025-03-10 Dickinson Andrew D Chief Financial Officer Grant or award · Non-qualified Stock Option (Right to Buy) 10b5-1 +49,020 49,020
2025-03-10 Dickinson Andrew D Chief Financial Officer Grant or award · Restricted Stock Unit 10b5-1 +11,090 38,609
2025-03-10 Patterson Sandra SVP, Controllership Option exercise +1,952 40,077
2025-03-10 Patterson Sandra SVP, Controllership Shares withheld for taxes −624 $117.21 $73K 39,453
2025-03-10 Patterson Sandra SVP, Controllership Option exercise · Restricted Stock Unit −1,952 9,875
2025-03-10 Berger Dietmar Chief Medical Officer Grant or award · Restricted Stock Unit +8,530 57,505
2025-03-10 Berger Dietmar Chief Medical Officer Grant or award · Non-qualified Stock Option (Right to Buy) +37,710 37,710
2025-02-18 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −2,500 $104.09 $260K 169,061
2025-02-12 Dickinson Andrew D Chief Financial Officer Option exercise 10b5-1 +77,691 $63.91 $5.0M 248,914
2025-02-12 Dickinson Andrew D Chief Financial Officer Option exercise 10b5-1 +26,175 $57.92 $1.5M 275,089

Page 19 of 30 · 599 trades